Humacyte, Inc. (HUMA) Reports In-Line Q3 EPS

Humacyte, Inc. (NASDAQ: HUMA) reported Q3 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins